Enhanced Characterization of Contractility in Cardiomyocytes During Early Drug Safety Assessment

Authors:

Abstract
We sought to investigate whether drug-induced changes in contractility were affected by pacing rates that represent the range of heart rates encountered in vivo. Using the cell geometry measurement system (IonOptix™), we paced dog cardiomyocytes at different cycle lengths (CLs) of 2000, 1000, 500 and 333.3ms, before and after exposure to 13 inotropic drugs. Time course data using vehicle control (0.1% DMSO) demonstrated stability of the system at all CLs tested. Seven positive inotropes (e.g., isoproterenol) exerted rate-dependent increases in sarcomere shortening (Sarc. short.; maximal effect at a CL of 333.3ms (0.1μM isoproterenol increased Sarc. short. by 41.1% and 145.9% at 2000 and 333.3ms, respectively)). Omecamtiv mecarbil showed an atypical profile (increased Sarc. short. at 2000ms (106.9%) and decreased at 333.3ms (IC50=0.64μM)). Four negative inotropes (e.g., flecainide) showed rate-independent inhibition of Sarc. short. (IC50s: 3.3μM (2000ms) vs. 2.3μM (333.3ms)). The remaining negative inotropes, verapamil and BTS (N-benzyl-p-toluene sulphonamide) produced an increase (IC50s: 3.9μM (2000ms) vs. 0.043μM (333.3ms)) and decrease (IC50s: 18.3μM (2000ms) vs. 34.0μM (333.3ms)) in potency, respectively. Negative inotropes (e.g., flecainide, BTS and verapamil) decreased the area of the Ca2+ transient vs. Sarc. short. hysteresis loop, although rate dependency was seen with verapamil only. Positive inotropes (e.g., isoproterenol and levosimendan) induced a rate-dependent increase in the area, however Omecamtiv mecarbil increased and decreased the area at CLs of 2000 and 333.3ms, respectively. Thus, the use of different pacing rates may improve the detection of inotropes in early drug discovery and illustrate the potential for finger-printing different mechanisms of action.

This publication has 43 references indexed in Scilit: